Drugs & Targets Palmetto GBA publishes CMS coverage policy for Decipher prostate cancer classifier January 23, 2015Vol.41 No.03
Drugs & TargetsFree Accelerated Approval Granted To Opdivo in Metastatic Melanoma January 09, 2015Vol.41 No.01
Drugs & TargetsFree Polaris Group’s lead product candidate, ADI-PEG 20 receives US and EU orphan designations January 09, 2015Vol.41 No.01
Drugs & TargetsFree Amgen and Kite Pharma entered into a strategic research collaboration January 09, 2015Vol.41 No.01
Drugs & TargetsFree FDA approved a supplemental biologics license application for Gazyva January 06, 2015Vol.41 No.01
Drugs & Targets FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza January 02, 2015Vol.37 No.12
